Literature DB >> 19933504

Mortality predictors in a 60-year follow-up of adolescent males: exploring delinquency, socioeconomic status, IQ, high-school drop-out status, and personality.

Susan L Trumbetta1, Benjamin K Seltzer, Irving I Gottesman, Kathleen M McIntyre.   

Abstract

OBJECTIVE: To examine whether socioeconomic status (SES), high school (HS) completion, IQ, and personality traits that predict delinquency in adolescence also could explain men's delinquency-related (Dq-r) mortality risk across the life span.
METHODS: Through a 60-year Social Security Death Index (SSDI) follow-up of 1812 men from Hathaway's adolescent normative Minnesota Multiphasic Personality Inventory (MMPI) sample, we examined mortality risk at various ages and at various levels of prior delinquency severity. We examined SES (using family rent level), HS completion, IQ, and MMPI indicators simultaneously as mortality predictors and tested for SES (rent level) interactions with IQ and personality.
RESULTS: We ascertained 418 decedents. Dq-r mortality peaked between ages 45 years to 64 years and continued through age 75 years, with high delinquency severity showing earlier and higher mortality risk. IQ and rent level failed to explain Dq-r mortality. HS completion robustly conferred mortality protection through ages 55 years and 75 years, explained IQ and rent level-related risk, but did not fully explain Dq-r risk. Dq-r MMPI scales, Psychopathic Deviate, and Social Introversion, respectively, predicted risk for and protection from mortality by age 75 years, explaining mortality risk otherwise attributable to delinquency. Wiggins' scales also explained Dq-r mortality risk, as Authority Conflict conferred risk for and Social Maladjustment and Hypomania conferred protection from mortality by age 75 years.
CONCLUSIONS: HS completion robustly predicts mortality by ages 55 years and 75 years. Dq-r personality traits predict mortality by age 75 years, accounting, in part, for Dq-r mortality.

Entities:  

Mesh:

Year:  2009        PMID: 19933504     DOI: 10.1097/PSY.0b013e3181bfd7d8

Source DB:  PubMed          Journal:  Psychosom Med        ISSN: 0033-3174            Impact factor:   4.312


  6 in total

1.  REMAP-a Resilience Resources Measure for Prediction and Management of Somatic Symptoms.

Authors:  William B Malarkey; Prabu David; Jean-Philippe Gouin; Michael C Edwards; Maryanna Klatt; Alex J Zautra
Journal:  Int J Behav Med       Date:  2016-12

2.  Mortality of young offenders: a national register-based follow-up study of 15- to 19-year-old Finnish delinquents referred for forensic psychiatric examination between 1980 and 2010.

Authors:  Nina Lindberg; Jouko Miettunen; Anni Heiskala; Riittakerttu Kaltiala-Heino
Journal:  Child Adolesc Psychiatry Ment Health       Date:  2017-08-08       Impact factor: 3.033

3.  Association of a Crime Prevention Program for Boys With Mortality 72 Years After the Intervention: Follow-up of a Randomized Clinical Trial.

Authors:  Brandon C Welsh; Steven N Zane; Gregory M Zimmerman; Alexis Yohros
Journal:  JAMA Netw Open       Date:  2019-03-01

4.  Could an Innovative Training Program Including Contact Sports and Counseling Help Young People With Traits of Psychopathy and A History of School Dropout?

Authors:  Federica Sancassiani; Maria Efisia Lecca; Elisa Pintus; Maria Francesca Moro; Roberto Caria; Luigi Minerba; Quirico Mela; Antonio Egidio Nardi; Sergio Machado; Ernesto d'Aloja; Antonio Preti; Mauro Giovanni Carta
Journal:  Clin Pract Epidemiol Ment Health       Date:  2019-03-26

5.  Adolescents in a residential school for behavior disorders have an elevated mortality risk in young adulthood.

Authors:  Marko Manninen; Maiju Pankakoski; Mika Gissler; Jaana Suvisaari
Journal:  Child Adolesc Psychiatry Ment Health       Date:  2015-09-02       Impact factor: 3.033

6.  Adolescent conduct problems and premature mortality: follow-up to age 65 years in a national birth cohort.

Authors:  B Maughan; M Stafford; I Shah; D Kuh
Journal:  Psychol Med       Date:  2013-08-21       Impact factor: 7.723

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.